O., Corkey, B
Then, in September, the Trump Administration launched a crackdown on deceptive direct-to-consumer drug advertising, resulting in the FDA publishing over 55 warning letters to online sellers of compounded versions of GLP-1 medications that called for the removal of false and misleading promotional statements, claims of clinically proven weight-loss treatments, and using the words FDA-approved in advertising copy
The regulatory environment actually favors compounded access during brand-name shortages
Unregulated products also carry infection and contamination risks, so your surgeon will advise based on your procedure and medical history
Association between diabetes, obesity, aging, and cancer: Review of recent literature
Until then, patients should focus on safe, available, evidence-based care